Galbraith Kenneth (CIK 1567045) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-12). Recent activity: Buy ZYME (64,000 shares), Sell ZYME (30,424 shares), Buy ZYME (47,668 shares), Sell ZYME (22,657 shares), Buy ZYME (66,666 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-12 | Zymeworks Inc. (ZYME) | Chair & CEO | Buy | 64,000 | $0 |
| 2026-01-12 | Zymeworks Inc. (ZYME) | Chair & CEO | Sell | 30,424 | $689,712 |
| 2026-01-05 | Zymeworks Inc. (ZYME) | Chair & CEO | Buy | 47,668 | $0 |
| 2026-01-05 | Zymeworks Inc. (ZYME) | Chair & CEO | Sell | 22,657 | $568,691 |
| 2026-01-05 | Zymeworks Inc. (ZYME) | Chair & CEO | Buy | 66,666 | $0 |
| 2026-01-05 | Zymeworks Inc. (ZYME) | Chair & CEO | Sell | 31,686 | $795,319 |
| 2025-12-22 | Zymeworks Inc. (ZYME) | Chair & CEO | Buy | 100,000 | $0 |
| 2025-12-22 | Zymeworks Inc. (ZYME) | Chair & CEO | Sell | 47,528 | $1.3M |
Source: SEC Form 4 filings · as of 2026-01-12